Press release
Tempus AI, Inc. (NASDAQ: TEM) Shareholder Notice: Deadline in Lawsuit on August 12, 2025
A Deadline is coming up on August 12, 2025 in the lawsuit for certain investors in Tempus AI, Inc. (NASDAQ: TEM).
Investors who purchased shares of Tempus AI, Inc. (NASDAQ: TEM) have certain options and there are strict and short deadlines running. Deadline: August 12, 2025. NASDAQ: TEM stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the Northern District of Illinois the plaintiff alleges on behalf of purchasers of Tempus AI, Inc. (NASDAQ: TEM) common shares between August 6, 2024 and May 27, 2025, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between August 6, 2024 and May 27, 2025, Tempus AI, Inc. branded itself as an AI company despite having little history of generating significant revenues from AI solutions; instead, the Company generated most of its revenues from acquisitions, genomic testing and data licensing agreements, that the Defendants repeatedly claimed that the contract value and quality of its data licensing agreements with life science companies were secure and expanding, that Tempus AI, Inc. often reported on its relationship with long-term customer AstraZeneca as an example, that importantly between August 6, 2024 and May 27, 2025, Tempus AI, Inc. announced an expanding contract with AstraZeneca via a joint venture between the Company, AstraZeneca and Pathos AI, that the Company similarly announced a joint venture with SoftBank as a way to generate revenue growth by entering the Japanese market, that Tempus AI, Inc. additionally claimed high revenue potential for Ambry Genetics ("Ambry"), a target it acquired between August 6, 2024 and May 27, 2025, and that Tempus AI, Inc. claimed that Ambry's accelerated growth was on account of its strong relationships with health care providers.
Those who purchased shares of Tempus AI, Inc. (NASDAQ: TEM) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Tempus AI, Inc. (NASDAQ: TEM) Shareholder Notice: Deadline in Lawsuit on August 12, 2025 here
News-ID: 4142884 • Views: …
More Releases from Shareholders Foundation, Inc.
Long-Term Investors in shares of Molina Healthcare, Inc. (NYSE: MOH) should cont …
An investigation on behalf of current long-term investors in shares of Molina Healthcare, Inc. (NYSE: MOH concerning potential breaches of fiduciary duties by certain directors and officers of Molina Healthcare, Inc. was announced.
Investors who are current long term investors in Molina Healthcare, Inc. (NYSE: MOH) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law…
Cepton, Inc. (formerly NASDAQ: CPTN) Investor Alert: Investigation of potential …
An investigation on behalf of investors in shares of Cepton, Inc. (formerly NASDAQ: CPTN) concerning potential breaches of fiduciary duties by certain directors and officers was announced.
Investors who are current long term investors in Cepton, Inc. (formerly NASDAQ: CPTN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for investors in formerly NASDAQ:…
Investigation announced for long term investors in shares of Spirit Aviation Hol …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Spirit Aviation Holdings, Inc.
Investors who are current long term investors in Spirit Aviation Holdings, Inc. (OTC: FLYYQ) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in OTC: FLYYQ stocks follows a…
ALERT: Lawsuit filed for Investors who lost money with shares of Bath & Body Wor …
An investor, who purchased shares of Bath & Body Works, Inc. (NYSE: BBWI), filed a lawsuit over alleged violations of Federal Securities Laws by Bath & Body Works, Inc.
Investors who purchased shares of Bath & Body Works, Inc. (NYSE: BBWI) have certain options and for certain investors are short and strict deadlines running. Deadline: March 16, 2026. NYSE: BBWI investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call…
More Releases for Tempus
AI in Clinical Trials Market: Regaining Its Glory | IBM Watson, Tempus, Oracle
AI in clinical trials refers to the application of artificial intelligence technologies to enhance the efficiency and effectiveness of clinical research processes. This includes utilizing machine learning algorithms for data analysis, patient recruitment, and monitoring outcomes, ultimately aiming to speed up drug development and improve patient outcomes. The integration of AI in clinical trials is transforming the landscape of medical research, enabling more precise and personalized approaches to treatment while…
Genomics In Cancer Care Market is Booming Worldwide |Invitae,Helix, Tempus
HTF MI just released the Global Genomics In Cancer Care Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major Manufacturers are covered: Foundation Medicine (United States), Guardant…
Predictive Disease Analytics Market Is Booming So Rapidly | Tempus, Verily, Pala …
The Global Predictive Disease Analytics Market Size is estimated at $3.5 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 21.4% to reach $20 Billion by 2034.
The latest study released on the Global Predictive Disease Analytics Market by USD Analytics Market evaluates market size, trend, and forecast to 2034. The Predictive Disease Analytics market study covers significant research data and proofs to be a handy…
AI in Medical Diagnostics Market Is Booming So Rapidly | Aidoc, Tempus, Lunit
USD Analytics recently introduced Global AI in Medical Diagnostics Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2024-2032). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are IBM Watson Health, GE Healthcare, Siemens Healthineers, Zebra…
AI in Oncology Market SWOT Analysis by Leading Expert: Tempus, Oncora, PerkinElm …
USD Analytics recently introduced Global AI in Oncology Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2024-2032). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are IBM Watson Health, Tempus, GE Healthcare, Siemens Healthineers, Varian…
Artificial Intelligence In Precision Medicine Market Is Booming So Rapidly: IBM, …
The latest study released on the Global Artificial Intelligence In Precision Medicine Market by USD Analytics Market evaluates market size, trend, and forecast to 2032. The Artificial Intelligence In Precision Medicine market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming…
